Taipei, Aug. 16 (CNA) Moderna's second-generation COVID-19 vaccine is currently under review for emergency use authorization (EUA) and could be delivered to Taiwan as early as September, the Central Epidemic Command Center (CECC) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan disputes poor climate change ranking
12/09/2023 10:54 PM - Politics
DPP's Lai calls Taiwan an exemplar of democracy and economic performance
12/09/2023 10:32 PM - Sports
Taiwan to vie for baseball tourney title after topping Philippines
12/09/2023 10:21 PM - Business
Housing market in northern Taiwan stays stable in November
12/09/2023 09:11 PM - Business
Pace of Taiwanese banks New Southbound expansion slows
12/09/2023 07:30 PM